Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
12/13/1995 | EP0686142A1 Polyamine derivatives as radioprotective agents |
12/13/1995 | EP0686045A1 Excipient stabilization of polypeptides treated with organic solvents |
12/13/1995 | EP0686034A1 Bisacodyl dosage form |
12/13/1995 | EP0686032A1 Use of 2-chloro-1- 4- (2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for the selective treatment of enteroviral infections in humans |
12/13/1995 | EP0686025A1 Titanium dioxide dispersions, cosmetic compositions and methods for using the same |
12/13/1995 | EP0686024A1 Thickening mixture based on guar gum or non-ionic cellulose and a cross-linked polymer, and cosmetic or dermatological hair- or skin-care composition containing said mixture |
12/13/1995 | EP0526524B1 Pharmaceutical compositions |
12/13/1995 | EP0521988B1 Device for iontophoretic drug delivery |
12/12/1995 | US5475096 Binding to three-dimensional targets |
12/12/1995 | US5475092 Deliver cytotoxic drugs to specific cell population in targeted fashion |
12/12/1995 | US5475052 Collagen-synthetic polymer matrices prepared using a multiple step reaction |
12/12/1995 | US5475023 Aqueous pharmaceutical formulations of sodium cromoglycate |
12/12/1995 | US5474980 Prolonged release of biologically active somatotropins |
12/12/1995 | US5474979 Nonirritating emulsions for sensitive tissue |
12/12/1995 | US5474978 Insulin analog formulations |
12/12/1995 | US5474780 Monolithic maleic anhydride drug delivery systems |
12/12/1995 | US5474779 Compositions for aiding in the regeneration of tissue with a prolonged immunomodulating effect |
12/12/1995 | US5474771 Inhibits T cell activation of B cells ; binds to epitope |
12/12/1995 | US5474768 Vaginal tissue moisturizing composition and method |
12/12/1995 | US5474767 Polyamines and method for preparation thereof |
12/12/1995 | US5474765 Drug delivery; heparin/steroid conjugates; selectively hydrolyzable linkage e.g, an acid labile or enzyme-sensitive bond; angiogenesis inhibitors; anticarcinogenic,-arthritic and diabetic agents |
12/12/1995 | US5474764 Alkaline ophthalmic suspensions |
12/12/1995 | US5474760 Method of inhibiting oxidants using alkylaryl polyether alcohol polymers |
12/12/1995 | US5474759 Non-chlorofluorocarbon aerosol formulations |
12/12/1995 | US5474718 Starch hydrolysates as sequesterers |
12/12/1995 | CA2010692C Gelatin capsules containing ranitidine |
12/07/1995 | WO1995033061A1 Method for introducing nucleic acid in higher eukaryotic cells |
12/07/1995 | WO1995032992A1 Synthetic peptide analogs of lung surfactant protein sp-c |
12/07/1995 | WO1995032985A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer |
12/07/1995 | WO1995032741A1 Bile acid conjugates, derivatives thereof with metal complexes and related uses |
12/07/1995 | WO1995032739A1 Cyclodextrin cellular delivery system for oligonucleotides |
12/07/1995 | WO1995032738A1 Modification of clostridial toxins for use as transport proteins |
12/07/1995 | WO1995032737A1 Pharmaceutical composition |
12/07/1995 | WO1995032735A2 Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease |
12/07/1995 | WO1995032730A1 A pharmaceutical preparation comprising glucagon |
12/07/1995 | WO1995032726A1 Cyclosporin containing composition and process for the preparation thereof |
12/07/1995 | DE4419724A1 Lagerstabiles und diffusionsdichtes Mikrokapselwandmaterial A shelf-stable and diffusion-tight microcapsule wall material |
12/07/1995 | DE4418965A1 Transfection of eukaryotic cells with nucleic acid |
12/07/1995 | CA2191777A1 Cyclodextrin cellular delivery system for oligonucleotides |
12/07/1995 | CA2191762A1 Method for introducing nucleic acid in higher eukaryotic cells |
12/07/1995 | CA2191317A1 A pharmaceutical preparation comprising glucagon |
12/07/1995 | CA2190982A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer |
12/07/1995 | CA2190598A1 Pharmaceutical composition |
12/06/1995 | EP0685457A1 Glycerol derivative, device and pharmaceutical composition |
12/06/1995 | EP0685235A1 Extracts of piliostigma thonningii, the use thereof and formulations containing them |
12/06/1995 | EP0685234A1 Drug composition containing nucleic acid copolymer |
12/06/1995 | EP0685232A2 Cefixim formulation |
12/06/1995 | EP0685231A2 Water-dispersible tablet containing lamotrigine |
12/06/1995 | EP0685230A1 Stable dermatologic preparation containing mycophenolic acid |
12/06/1995 | EP0684997A1 Anthrax toxin fusion proteins and uses thereof |
12/06/1995 | EP0684841A1 Protein conjugates, compositions containing them and their applications as medicament |
12/06/1995 | EP0684840A1 Method of preparing colloidal aqueous solutions of active substances which are only slightly soluble in water, and a lipid for use in the method |
12/06/1995 | EP0684839A1 Process for preparing colloidal aqueous solutions of hardly soluble active substances |
12/06/1995 | EP0684814A1 Compositions for oral delivery of active agents |
12/06/1995 | EP0684808A1 Light stable color compositions |
12/06/1995 | EP0684806A1 Transmucosal delivery of macromolecular drugs |
12/06/1995 | EP0673259A4 A method for transplanting cells into the brain and therapeutic uses therefor. |
12/06/1995 | EP0647131B1 Dermatological agent for aiding oxygen transport in the skin |
12/06/1995 | EP0647129B1 Topical application composition |
12/06/1995 | EP0557512B1 Utilization in cosmetic or topical applications of an aqueous dispersion based on organopolysiloxanes and a crosslinked copolymer of acrylamide/neutralized 2-acrylamido 2-methylpropane sulfonic acid |
12/06/1995 | EP0490998B1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates |
12/06/1995 | EP0445255B1 Treatment of conditions and disease |
12/06/1995 | CN1113074A Aqueous composition |
12/06/1995 | CN1112935A Acylierte gamma-cyclodextrine |
12/05/1995 | US5473055 Antitumor agents; better water solubility, side effect reduction |
12/05/1995 | US5472982 Emulsified external treatment composition containing diclofenac sodium |
12/05/1995 | US5472954 Cyclodextrin complexation |
12/05/1995 | US5472950 Compositions containing cobalt hyaluronic acid complex |
12/05/1995 | US5472946 Transdermal penetration enhancers |
12/05/1995 | US5472944 Suppression of megakaryocytopoiesis by neutrophil activating peptide-2 |
12/05/1995 | US5472938 Pharmaceutical depot compositions containing hirudin |
12/05/1995 | US5472712 A drug substrate containing an active agent coated with ethyl cellulose being cured at a temperature greater than the glass transition temperature; storage stability, sustained release |
12/05/1995 | US5472711 Controlled release solid oral dosage form |
12/05/1995 | US5472707 High dose ranolazine formulations |
12/05/1995 | US5472706 Dry compositions for preparing submicron emulsions |
12/05/1995 | US5472705 Pharmaceutical composition containing esters of ω-3 polyunsaturated acids and their use in the topical treatment of morbid affections |
12/05/1995 | US5472704 Pharmaceutical controlled-release composition with bioadhesive properties |
12/05/1995 | US5472689 Hair cosmetic composition containing a poly(N-acylalkyleneimine)-organopolysiloxane block or graft copolymer |
12/05/1995 | CA2047903C Calcitonin-containing emulsion for nasal administration |
12/05/1995 | CA2012875C Skin permeation enhancer compositions |
12/05/1995 | CA1337688C Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants |
12/02/1995 | CA2127762A1 Extracts from piliostigma thonningii, the use thereof and formulations containing them |
12/01/1995 | CA2150442A1 Cefixime composition |
11/30/1995 | WO1995032003A1 Modified insulin-like growth factors |
11/30/1995 | WO1995032002A1 Covalent microparticle-drug conjugates for biological targeting |
11/30/1995 | WO1995032001A1 Photodynamic conjugates with biocidal properties |
11/30/1995 | WO1995031979A1 Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions |
11/30/1995 | WO1995031978A1 Anti-acne compositions |
11/30/1995 | WO1995031976A1 Transdermal delivery of anti-epileptic drugs |
11/30/1995 | WO1995031971A1 Method for stabilizing duocarmycin derivatives |
11/30/1995 | WO1995031969A1 Pharmaceutical compositions derived from microelmulsion-based gels, method for their preparation and new microemulsion-based gels |
11/30/1995 | WO1995031968A1 Non-steroidal anti-inflammatory ophthalmic suspensions |
11/30/1995 | WO1995031966A1 Antimicrobial oil-in-water emulsions |
11/30/1995 | WO1995031956A1 Antibacterial oil-in-water emulsions |
11/30/1995 | DE4421391C1 Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression Use of antibodies against T-cells for prolonged immunosuppression |
11/30/1995 | DE4416001A1 Composite of homogeneous mol. dispersion of cpd. metal oxide matrix |
11/30/1995 | DE4411414C1 Produkt zur enteralen Versorgung mit Fettsäuren und/oder Aminosäuren sowie Verfahren zur Herstellung eines derartigen Produktes Product for enteral supply of fatty acids and / or amino acids, and methods for making such product |
11/30/1995 | CA2191195A1 Photodynamic conjugates with biocidal properties |
11/30/1995 | CA2190869A1 Pharmaceutical compositions derived from microelmulsion-based gels, method for their preparation and new microemulsion-based gels |
11/30/1995 | CA2190752A1 Modified insulin-like growth factors |